Researchers use genetics to develop cancer meds from bacteria

07/9/2013 | Business Weekly (U.K.)

Researchers at the University of East Anglia are working on new cancer treatments that address a fundamental cause of chemotherapy resistance. The research centers on a type of antibiotic produced by Streptomyces bacteria, which live symbiotically with leaf cutter ants. "We're using genetics to understand how the drugs are made in the bacteria so we can tweak the characteristics in favor of anti-cancer action, whilst protecting healthy cells," lead researcher Matt Hutchings said. "We want to make Streptomyces into a factory to produce a new type of chemotherapy drug on a large scale."

View Full Article in:

Business Weekly (U.K.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR